Skip to content

Clinical trials

Completed Phase 3 Musculoskeletal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 3 Status: Completed Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20096
20122
20132
20154
20164
20175
20181
20201
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
Regeneron Pharmaceuticals4
Amgen3
Genzyme, a Sanofi Company3
Intermountain Health Care, Inc.2
Organogenesis2
PTC Therapeutics2
BioMarin Pharmaceutical1
Catabasis Pharmaceuticals1
Kangbuk Samsung Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases31
Arthritis14
Joint Diseases14
Genetic Diseases, Inborn8
Rheumatic Diseases7
Bone Diseases6
Neuromuscular Diseases6
Arthritis, Rheumatoid5
Gout4
Metabolic Diseases4

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.